Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,402 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,695 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,049 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,049 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,494 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 6,714 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 8,185 shares (to pay taxes)
  8. 4 Planned sale VP, Finance (Interim PAO) sold 3,743 shares at $35.26 ($131,978)
  9. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 5,741 shares (to pay taxes)
  10. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 6,003 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 8,866 shares (to pay taxes)
  12. 4 Planned sale VP, Finance (Interim PAO) sold 1,327 shares at $35.69 ($47,361)
  13. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,869 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 2,822 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 1,869 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,950 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,950 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Planned sale EVP R&D, Chief Medical Officer sold 349,340 shares at an average $33.92 ($11,848,975)
  20. 144 Insider Sale of Securities

Page 10 of 97 · 1,927 filings